1 not yet recruiting. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Not yet recruiting 1 |
Follow Michel Duval: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase I Clinical Trial of ThINKK Adoptive Immunotherapy After Allogeneic Hematopoietic Transplantation in Children With Leukemia or Neuroblastoma Therapeutic Inducers of Natural Killer Killing (ThINKK) - Leukaemia (Acute Lymphoblastic), Leukaemia (Acute Myeloid) | Phase 1 | Not yet recruiting | Michel Duval | 12 | 2026-05-01 | 2026-04-08 |
Leukemia (1) · Leukemia, Myeloid, Acute (1) · Neoplasm Metastasis (1) · Neuroblastoma (1) · Paroxysmal nonkinesigenic dyskinesia (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)
Canada (1)